Advertisement

Banner Fairtec GmbH Worldwide Event Solutions 600x60px
All > Germany >

Deals > Northern Germany

Find below deals from the Northern German Federal States of Bremen (HB), Hamburg (HH), Mecklenburg-Vorpommern (MVP), Niedersachsen (NS) and Schleswig-Holstein (SWH). Listed are deals for this region as well as from organisations located there.

Total search results: 1603 | Ordered by Date (descending)
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page

order ascendingorder descendingDeal: Collaboration or Financing order ascendingorder descendingDate
Bruker Corp–Max Planck: mass spectrometry s/w, 201406 collab MaxQuant proteomics s/w supporting Bruker UHR-QTOF MS with MPI Matthias Mann group 2014-06-16
Merck (DE)–Sysmex: molecular companion diagnostics, 201406– collab developm + commercialisation blood-based RAS biomarker mutation status test 2014-06-01
Biobase–Qiagen: investment, 201405 acquisition €na by Qiagen 2014-05-20
Eternygen–Evotec: drug discovery services, 201405– colllab identification + developm small-molecule inhibitors agianst target in metoblic disease 2014-05-06
AllPure Technologies–Sartorius: investment, 201404– acquisition of majority stake €na by Sartorius Stedim Biotech signed 2014-04-28
Biobase–Murdoch Childrens Research Institute: POSSUMweb database, 201404– distribution ww excl by Biobase GmbH 2014-04-24
European ScreeningPort–Fraunhofer: investment, 201406 restructuring of ESP becoming part of Fraunhofer IME 2014-04-23
Diana–Symrise: investment, 201404– planned acquistion €1.3b ANNOUNCED 2014-04-12
Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Austria 2014-04-09
Omni Life Science–ACEA Biosciences: cell analysis technology, 201404 collab OLS is excl distributor for ACEA in Germany 2014-04-09
Protea Biosciences–Bruker Corp: mass spectrometer, 201404 supply + installation of UltrafleXtreme MALDI TOF/TOF mass spectrometer for MS imaging 2014-04-08
Debiopharm–Evotec: drug discovery services, 201404– collab + licensing discovery + developm of cancer drugs 2014-04-02
Convergence Pharmaceuticals–Evotec: drug discovery services, 201403– collab €na pain drug r+d with Panion Ltd 2014-03-31
Univ Oulu–Bruker Corp: mass spectrometer, 201403 supply existent UltrafleXtreme MALDI Tof/Tof listed on web site of MS Core Facility 2014-03-30
Bionamics–Evotec: investment, 201403 acquisition €na 100% against cash + future milestone payments 2014-03-24
Evotec–Reach Separations: chromatography, 201403– collab with Reach becoming technology partner providing small molecule chromatography 2014-03-19
Sysmex–Roche: PCR technology, 201402– license ww non-excl for emPCR patent portfolio to Sysmex Inostics GmbH 2014-02-21
Werum–Körber: investment, 201402– acquisition of newly formed Werum IT Solutions AG by Körber Medipak ANNOUNCED 2014-02-10
LABiTec–HUMAN Diagnostics Worldwide: investment, 201401 acquisition €na of LAbor BioMedical Technologies GmbH 2014-01-30
Axel Semrau–Bruker Corp: GC/MS solutions, 201401– collab configuration + sale of automated GC/MS solutions by Semrau using SCION TQ GC/MS systems 2014-01-21
Probi–Symrise: investment, 201401– mandatory offering SEK40.1/share for all remaining shares of Probi AB after increase of Symrise holdings to 30.03% 2014-01-10
Automation Partnership–Sartorius: investment, 201310–201312 acquisition €33m in cash of TAP Biosystems Group plc by Sartorius Stedim Biotech GmbH 2013-12-16
Euroimmun–Mecklenburg-Vorpommern (govt): grant, 201312– grant €3.15m to support total Euroimmun €14m investment to expand Dassow facility 2013-12-04
MeVis–PERSON: investment, 201311 shareholding of voting rights of Carl JG Evertsz has fallen to 14.995% 2013-11-11
JnJ–Evotec: drug discovery services, 201311– collab drug target discovery for Alzheimer drugs with JnJ Innovation Centre California 2013-11-08
Thermo Fisher–Univ Utrecht: mass spectrometry, 201311– collab developm applications + appointm of A Makarov as Professor 2013-11-04
IROA Technologies–Bruker Corp: mass spectrometer, 201310 supply existent IROA uses Bruker MS for metabolomics research 2013-10-31
AstraZeneca–Evotec: kidney disease drugs, 201310– license + collab agreem €na giving AZ access to selected series of molecules to treat CKD 2013-10-21
CV genes-at-target project–Evotec: genomic drug target discovery, 2013– collab European ScreeningPort is partner in FP7 project 2013-10-15
CV genes-at-target project–Univ Lübeck: genomic drug target discovery, 2013– collab Univ of Lübeck is partner in FP7 project 2013-10-15
Bayer–Sysmex: molecular companion diagnostics, 201310– collab master agreem for developm of blood-based CDx for cancer drugs by Sysmex Inostics 2013-10-09
Sartorius–PERSON: investment, 201310 existent family of the late Horst Satorius owns 50.09% bound by last will of Horst Satorius 2013-10-09
Findeisen Laborbedarf–Omnilab (DE): investment, 201310 acquisition of Findeisen Laborbedarf GmbH by Omnilab-Laborzentrum GmbH & Co KG 2013-10-01
Indivumed–Sysmex: investment, 201309–201310 acquisition of 100% of Inostics GmbH + its subsidiary Inostics Inc by Sysmex Corp 2013-09-25
Microstim–SEVERAL: investment, 201309 financing round €500k MVP + HTGF + Fides Finanz-Invest 2013-09-17
Bruker Corp–Siscapa: SISCAPA assay technology, 201309– collab extension developm SISCAPA-MALDI workflows + installation in demo facility 2013-09-16
Evotec–Harvard Univ: drug discovery, 201309– collab €na drug discovery for ALS using iPS cells with HSCI 2013-09-12
Q-Bioanalytic–EU (govt): grant, 201309–201608 FP7 grant €670k as member of DIAGMAL project 2013-09-01
Evotec–BVF Partners: investment, 201308 capital increase €30m 11.8m new shares €2.55/share to Biotechnology Value Fund LP 2013-08-31
Omnilab (DE)–Serva Electrophoresis: electrophoresis, 201308– distribution of Serva products + reagents by Onmilab 2013-08-22
Eppendorf–Manufactus: manufacturing software, 201308– supply use of eKanban System IKS by Eppendorf Liquid Handling GmbH 2013-08-16
Axa–Klocke: investment, 201308–201311 acquisition €na of Animal Health div of Riemser Pharma GmbH + production facility in Riems by IDT Biologika 2013-08-01
Capical–SEVERAL: investment, 201307 financing Series A from M-Invest + KfW 2013-07-30
Poonawalla–Deutsche Stiftung Impfstoffforschung: tuberculosis vaccine, 201307– acquisition of rights to VPM1002 by Serum Institute of India from VPM 2013-07-23
CI3 Cluster–Avia: personalised immunotherapy, 201307 collab existent Avia Industrial Services GmbH is cluster partner 2013-07-21
CI3 Cluster–Euroimmun: personalised immunotherapy, 201307 collab existent Euroimmun AG is cluster partner 2013-07-21
CI3 Cluster–Germany (govt): personalised immunotherapy, 201307 collab existent Friedrich Loeffler Institute is cluster partner 2013-07-21
Sartorius–BlueSens: gas analyser, 201307– collab co-marketing as private label products under SSB brand BioPAT Xgas 2013-07-16
CLC bio–SciEngines: bioinformatics, 201307 collab integration of CLC sequence analysis s/w with SciEngines Rivyera computers 2013-07-09
Dow–Evotec: chemical services, 201307– collab research €na chemical proteomics services to support compound developm at Dow AgroSciences 2013-07-09
Bruker Corp–CovalX: mass spectrometry, 201306– collab ww support to combine CovalX high-mass systems with Bruker autoflex + ultraflex instruments 2013-06-06
Bruker Corp–3M: MALDI Imaging, 201306– license excl to technique for performing MS analysis on FFPE tissue 2013-06-04
Univ Hamburg–Bruker Corp: mass spectrometer, 201306 supply existent MALDI Molecular Imager used by Prof H Schlüter in FFPE prostate cancer study UKE 2013-06-04
Evotec–Harvard Univ: drug discovery, 201305– collab identification + optimisation of small molecule antibacterials 2013-05-16
Bruker Corp–SCiLS GmbH: SCiLS Lab s/w, 201305– collab excl partnership for use of SCiLS Lab s/w w Bruker MALDI Imaging solutions 2013-05-14
Univ Jena–Bruker Corp: mass spectrometer, 201305 supply Prof v Eggeling existent user of Bruker MALDI Imaging equipment 2013-05-14
Univ Jena–SCiLS GmbH: SCiLS Lab s/w, 201305 supply existent Prof v Eggeling is beta tester of SCiLS Lab s/w using Bruker MALDI Imaging equipment 2013-05-14
Evotec–Harvard Univ: drug discovery, 201304– collab target validation for epigenetics-guided cancer drug discovery Dana-Farber Cancer Institute 2013-04-30
Roche–Evotec: drug discovery services, 201304–201604 collab extension for 3 years discovery small molecule drugs for Genentech 2013-04-22
Rodos BioTarget–High-Tech Gründerfonds: investment, 201304 financing round €2.6m with Enjoy Venture + HTGF + KfW ERP Start Fund + private investors 2013-04-17
Rodos BioTarget–SEVERAL: investment, 201304 financing round €2.6m from Enjoy Venture + HTGF + KfW ERP Start Fund + private investors 2013-04-17
Monsanto–Dieckmann: seeds, 201304 acquisition €na part of European business incl rape + rye seeds by Monsanto Agrar Deutschland GmbH 2013-04-11
Univ Bremen–DFG (DE): grant, 201304– Core Facility grant 3 years up to €450k for MALDI-MULTI MALDI Imaging Core Facility 2013-04-01
Eppendorf–HB Technologies: software solutions, 201303 supply existent Eppendorf listed as life science customer 2013-03-18
Optimare–Aerodata: investment, 201303 acquisition €na of bankrupt Optimare Group by Aerodata AG 2013-03-01
Sartorius–Aber Instruments: sensor technology, 201302– co-developm + excl ww marketing + distribution of single-use sensors to biopharma market by SSB 2013-02-27
Evotec–Yale Univ: drug discovery, 201301– strategic partnership to combine Evotec drug discovery infrastructure with Yale research 2013-01-09
Prophyta–Bayer: investment, 201301 acquisition €na by Bayer CropScience 2013-01-08
AstraZeneca–Evotec: antidiabetics, 201301– collab + license agreem expansion + extension until end of 2013 with MedImmune 2013-01-07
Bruker Corp–Erasmus Univ: clinical diagnostics, 201301– license excl for MALDI-TOF-based beta-lactamase testing from EMC 2013-01-03
CCS Cell Culture Service–Evotec: investment, 201301 acquisition 100% for €1.15m in cash upfront + 1 year-milestone of €1.05 in cash 2013-01-03
Cevec–Deutsche Stiftung Impfstoffforschung: vaccine technology, 201301– license excl to CMV dense body techn for developm of CMV vaccine from VPM 2013-01-03
Apeiron–Evotec: cancer immunotherapy, 201301– collab €na development of lead compounds 2013-01-02
Innovative Medicines Initiative–Bruker Corp: antibiotics, 201301–201712 project partner Bruker Daltonik GmbH in €29.3m TRANSLOCATION project of IMI 2013-01-01
Innovative Medicines Initiative–European ScreeningPort: antibiotics, 201301–201712 partner in €29.3m TRANSLOCATION project of IMI 2013-01-01
Innovative Medicines Initiative–Ionovation: antibiotics, 201301–201712 project partner Ionovation GmbH in €29.3m TRANSLOCATION project of IMI 2013-01-01
Innovative Medicines Initiative–Jacobs Univ: antibiotics, 201301–201712 project coordinator in €29.3m TRANSLOCATION project of IMI 2013-01-01
Jacobs Univ–Bremen (govt): grant, 2013–2017 funding €15m over 5 years by Federal State of Bremen 2013-01-01
Omnilab (DE)–Bruker Corp: laboratory consumables, 201301– distribution of Bruker GC + MS consumables in Germany by Omnilab 2013-01-01
Sartorius–Lonza: cell culture media, 201212– collab €na global sales + marketing of media + buffers by SSB which takes over Lonza medial sales team 2012-12-19
Sartorius–MKS Instruments: cheminformatics, 201212– global marketing + distribution of Umetrics’ s/w for biopharma developm + manufacturing by SSB 2012-12-18
JnJ–Evotec: NMDA receptor NR2B subtype selective antagonists, 201212– license excl ww compound portfolio to treat depression 2012-12-17
Biobase–Univ Southern California: genomic s/w, 201212– distribution rights ww excl for ANNOVAR s/w from USC + CHOP 2012-12-05
Allergopharma–Merck (DE): investment, 201212 acquisition of all remaining interests by Merck who has been majority shareholder since founding 2012-12-01
Probiodrug–Evotec: drug development services, 201211– collab assay developm for prec-clinical + clinical developm of QC inhibitors for Alzheimer’s 2012-11-28
MVZ Dortmund–Orexo: IRIS analyser, 201211 supply existent 2012-11-23
Haplogen–Evotec: virostatic agents, 201211– collab €na discovery + developm of small molecules against viral infections 2012-11-15
GeneQuine–Hamburg (govt): investment, 201211 seed financing round totalling €1m incl €500k from Innovationsstarter Hamburg 2012-11-12
GeneQuine–High-Tech Gründerfonds: investment, 201211 seed financing round totalling €1m incl €500k from HTGF 2012-11-12
GeneQuine–SEVERAL: investment, 201211 seed financing round €1m from Innovationsstarter Hamburg + HTGF 2012-11-12
Bruker Corp–Thermo Fisher: UltiMate LC system, 201211 collab co-marketing of UltiMate 3000 Standard LC with amaZon SL system by Bruker 2012-11-09
CCS Cell Culture Service–Cevec: CAP-T technology, 201211– license to offer CAP-T cells for cell -based assays + protein production 2012-11-05
Cypher Genomics–Biobase: genomic software tools, 201211– supply Genome Trax Knowledgebase to be used by Cypher for sequencing variant analysis 2012-11-05
Bruker Corp–Horiba: SPRi-MALDI platform, 201211– product integration + co-marketing of integrated SPRi-MALDI-MS system 2012-11-01
Univ Maryland–Thermo Fisher: mass spectrometer, 201211c supply Thermo LTQ Orbitrap Velos MS w ETD + NanoLC system to MS Facility at School of Pharmacy 2012-11-01
3D-MASSOMICS project–EU (govt): grant, 201210– FP7 grant €2.8m 2012-10-30
EADS–Ionicon: mass spectrometer, 201210 supply existent PTR-TOF 8000 MS for several A330/A340 Airbus aircraft for air testing 2012-10-29
Thermo Fisher–Univ Utrecht: mass spectrometry, –201210 collab advancement of Orbitrap mass analyzer using Exactive Plus MS by AJR Heck + A Makarov 2012-10-22
Protea Biosciences–Thermo Fisher: mass spectrometer, 201210 supply existent LTQ Velos MS at newly opended MSIC 2012-10-20
Sweden (govt)–Bruker Corp: mass spectrometer, 201210 supply existent maXis impact incl use of new PesticideScreener solution at NFA 2012-10-05
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17  next pagenext page



Advertisement

Banner LSBC Central European Life Science Investment Conference 2014 600x60px

To subscribe to our free, monthly newsletter for the life sciences in German-speaking Europe (DE, AT & CH), please send an e-mail to info@iito.de and simply fill the subject line with the word »LSG newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)


Advertisement

The Events Group Pharm Connect Congress 2015 Budapest February 600x60px

» top

Advertisements

Banner BIO Deutschland European Business Development Conference 120x240px Banner LSBC Central European Life Science Investment Conference 2014 120x180px Banner EBD Group BIO Europe 2013 BEU Frankfurt November 120x180px Erfolgreicher Nischenanbieter im LC/MS-Markt sucht Junior-Partner 120x240px Banner Vego Ltd Ecochem Conference 2014 Basel 120x120px The Events Group Pharm Connect Congress 2015 Budapest February 120x180px Banner Fairtec GmbH Solutions for Smarter Business Events Exhibitions 120x120px Banner [iito] Twitter iitoLifeScience Life Sciences Mass Spec 120x120px